TY  - GEN
AU  - De Leeuw,I
AU  - Vague,P
AU  - Selam,J-L
AU  - Skeie,S
AU  - Lang,H
AU  - Draeger,E
AU  - Elte,J W F
TI  - Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin
SN  - 1462-8902
PY  - 2005///0412
KW  - Adult
KW  - Blood Glucose
KW  - analysis
KW  - Body Weight
KW  - drug effects
KW  - Diabetes Mellitus, Type 1
KW  - blood
KW  - Drug Administration Schedule
KW  - Female
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Insulin
KW  - administration & dosage
KW  - Insulin Detemir
KW  - Insulin, Isophane
KW  - Insulin, Long-Acting
KW  - Male
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1463-1326.2004.00363.x
ER  -